No Prescription |
 |
 | ||
|
Fosamax Generic Alendronate |
|
| ||
No Prescription » Prescription Drugs 8 » Fosamax Generic Alendronate Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Alendronate (a-LEN-dro-nate) is used to prevent or treat osteoporosis (thinning of the bone) in women after menopause and to treat osteoporosis in men. It may also be used to treat Paget's disease of bone and osteoporosis (thinning of the bone) caused by glucocorticoid treatment. Fosamax is prescribed for the prevention and treatment of osteoporosis the brittle bone disease in postmenopausal women. It is also used to increase bone mass in men with osteoporosis and is prescribed for both men and women who have developed a form of osteoporosis sometimes caused by steroid medications such as prednisone. This drug can also be used to relieve Paget's disease of bone a painful condition that weakens and deforms the bones. Alendronate is in the group of medicines called bisphosphonates (bis FOS fo nayts). It alters the cycle of bone formation and breakdown in the body. Alendronate slows bone loss while increasing bone mass which may prevent bone fractures. Alendronate is used to treat or prevent postmenopausal osteoporosis and steroid-induced osteoporosis. Alendronate is also used to treat Paget's disease of bone. Buy Fosamax Generic Alendronate and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About Fosamax Generic Alendronate: Product Type: Prescription Drugs 8 Fosamax ( Generic Alendronate ) Fosamax (Generic Alendronate) Generic Alendronate 70mg 10mg 40mg 4 Tablets 30 tabs Generic Alendronate Fosamax
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
